Epigenetic drug discovery and tools
 

Management and Board

Management

 

    Barrie Ward   Executive Chairman
    Will West   Chief Executive
    Tim Fell  Chief Operating Officer
    David Knowles  Chief Scientific Officer
    Nessa Carey  Scientific Director
    Neil Pegg Director of Discovery Research
    Jonathan Best Programme Manager
    Dev Crease  Patent Counsel
    Richard Brooks Finance Director
    Thea Stanway  Finance Officer

  

Board

 

    Barrie Ward  Executive Chairman
    Will West  Executive Director
    Tim Fell Executive Director
    David Knowles Executive Director
    Gerald Chan Non-Executive Director
    Sue Foden Non-Executive Director
    Dan Roach Non-Executive Director
    David Secher Non-Executive Director
    Azim Surani Board Observer
 

  

Will West (Chief Executive)   Board member

Will WestWill completed his PhD in immunology and virology in 1992, sponsored by Unilever (UniPath).  He held a post-doctoral position at the National Institute of Biological Standards and Control before joining Procter & Gamble Healthcare in 1994.  

 

He was responsible for clinical development in a number of therapeutic areas.  He led an international team and delivered programmes throughout Europe, the Americas, South Africa and China.  In 2001 he joined CellFactors plc, a tissue engineering biotechnology company in Cambridge, UK, where he was responsible for Product and Business Development.  

 

In 2004 he was recruited by Avlar BioVentures to help initiate CellCentric. Will holds a Masters degree in Clinical Research as well as an MBA from London Business School.  He chairs the committee for Emerging Companies for the BioIndustry Association and is on the Research Steering Group of a Wellcome Trust-backed tissue engineering company. He had active involvement with the UK government’s review of bioscience (BIGT initiative).  Will was appointed CEO in November 2005.